IsoPlexis

Jul 24, 2018

IsoPlexis Places IsoLight Single-Cell Proteomic Detection Instrument at Fred Hutchinson Cancer Research Center

Jun 26, 2018

IsoPlexis Announces Research Collaboration with Nektar Therapeutics

Jun 12, 2018

Clinical Data Highlighting Single-Cell Polyfunctionality as a Potential Predictor of Patient Response to CAR-T Cell Therapy Published in "Blood"

May 15, 2018

IsoPlexis Recognized with the Pharma Tech Outlook Cover Story as Top 10 Analytics Solution Provider in 2018

Apr 09, 2018

IsoPlexis' New IsoLight Instrument Receives the Red Dot Design Award for Highest Design Quality

Oct 23, 2017

IsoPlexis Receives $1.8M National Cancer Institute Grant To Develop Automated Platform To Assess CAR-T Product Potency and Toxicity and Predict Patient Response